• Latest Posts

Improved vision with less eye injections for patients after primary endpoints met in trials

Clearance given to clinical trial with potential to change course of brain disease

Ginkgo acquires Zymergen for $300M and picks up Bayer facility for $83M

Expansion into Europe for BlueRock Therapeutics

Big Pharma Strikes Megadeals In Targeted Protein Degradation

Farxiga’s Approval Fuels Chronic Kidney Disease Comeback


Women’s Health Gains Traction as Bayer Pays €736M for UK Firm

Meiogenix, Bayer Team Up to Boost Genetic Diversity in Crop Breeding

More News! 11 Jul 2019

Bayer Launches Israeli Company to Develop Viruses Against Crop Disease

Interview 20 Jun 2018

“Have the guts to follow your instincts”: Top CEO Talks About His Time in Biotech

More News! 17 May 2018

After settling lawsuit with Bayer, Cellectis spin-off launches €41M follow-on offering